cancer

For more cancer news, visit the Vanderbilt-Ingram Cancer Center website »

The Vanderbilt Ingram Cancer Center (Neil Brake/Vanderbilt)
October 29, 2012

Cancer research and education agreement announced between Baptist Memorial Health Care and Vanderbilt University

By VUMC News and Communications
October 18, 2012

Myelosuppression unit set to move to new CCT space

By VUMC News and Communications
October 4, 2012

Proteins help flip tumor’s invasive switch

Vanderbilt investigators have identified how two key components of cancer’s invasive “switch” — the series of signaling events that turn on a tumor cell’s invasive behavior — work together.

By Leigh MacMillan
September 27, 2012

Target acquired for aggressive tumor

New therapeutic target for angiosarcoma – an aggressive, highly fatal tumor of the blood vessels – identified.

By VUMC News and Communications
September 21, 2012

HER2 may impact lung cancer therapy

A protein associated with aggressive breast cancers may also influence resistance of lung cancer to targeted therapies.

By VUMC News and Communications
September 20, 2012

Photo: Signing up

By VUMC News and Communications
September 13, 2012

Carmaker’s gift boosts childhood cancer research

Patrick Grohar, M.D., Ph.D., was awarded a $250,000 Hyundai Hope on Wheels grant last week for his research into potential drug therapies for Ewing sarcoma, a cancer of the bone.
By Christina Echegaray
August 30, 2012

Vanderbilt-led study reveals racial disparities in prostate cancer care

Racial differences exist in quality surgical care, new research from VICC finds.
By VUMC News and Communications
August 23, 2012

Gene linked to familial prostate cancer

A rare, inherited mutation confers an eightfold increased risk of prostate cancer, a recent study shows.
By VUMC News and Communications
August 16, 2012

Method may refine personalized trials for cancer therapy

A new tool to observe cell behavior has revealed surprising clues about how cancer cells respond to therapy, and may offer a way to further refine personalized cancer treatments.
By VUMC News and Communications
August 9, 2012

Study links rare genetic marker to brain cancer

Investigators from Vanderbilt-Ingram Cancer Center and three other cancer centers have identified a link between a rare genetic variant and the risk of developing glioma.
By VUMC News and Communications
August 9, 2012

Young patient’s cancer battle inspires hometown

Maryville, Tenn., tucked in the foothills of the Great Smoky Mountains, has a population of just 27,000, but it seemed like every one of its residents rallied around 20-year-old Brently Mancini when he was diagnosed with a rare soft tissue cancer.
By VUMC News and Communications
August 2, 2012

Arteaga named to Komen scientific advisory board

Carlos Arteaga, M.D., associate director for Clinical Research and director of the Breast Cancer Program at Vanderbilt-Ingram Cancer Center (VICC), has been named to the Scientific Advisory Board of the Susan G. Komen for the Cure Breast Cancer Research Foundation.
By VUMC News and Communications